These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18318662)

  • 1. Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population.
    Linsel-Nitschke P; Götz A; Medack A; König IR; Bruse P; Lieb W; Mayer B; Stark K; Hengstenberg C; Fischer M; Baessler A; Ziegler A; Schunkert H; Erdmann J
    Clin Sci (Lond); 2008 Nov; 115(10):309-15. PubMed ID: 18318662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in the leukotriene pathway is associated with myocardial infarction in the Chinese population.
    Li Y; Xu X; Zhang D; Cheng W; Zhang Y; Yu B; Zhang Y
    Lipids Health Dis; 2019 Jan; 18(1):25. PubMed ID: 30678701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study.
    Girelli D; Martinelli N; Trabetti E; Olivieri O; Cavallari U; Malerba G; Busti F; Friso S; Pizzolo F; Pignatti PF; Corrocher R
    Eur J Hum Genet; 2007 Sep; 15(9):959-66. PubMed ID: 17505527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach.
    Zee RY; Cheng S; Hegener HH; Erlich HA; Ridker PM
    Stroke; 2006 Aug; 37(8):2007-11. PubMed ID: 16778124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific association of depression and a haplotype in leukotriene A4 hydrolase gene.
    Zhao J; Quyyumi AA; Patel R; Zafari AM; Veledar E; Onufrak S; Shallenberger LH; Jones L; Vaccarino V
    Psychosom Med; 2009 Sep; 71(7):691-6. PubMed ID: 19622707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of LTA4H and ALOX5AP polymorphism in asthma and allergy susceptibility.
    Holloway JW; Barton SJ; Holgate ST; Rose-Zerilli MJ; Sayers I
    Allergy; 2008 Aug; 63(8):1046-53. PubMed ID: 18547289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos.
    Via M; De Giacomo A; Corvol H; Eng C; Seibold MA; Gillett C; Galanter J; Sen S; Tcheurekdjian H; Chapela R; Rodríguez-Santana JR; Rodríguez-Cintrón W; Thyne S; Avila PC; Choudhry S; González Burchard E;
    Clin Exp Allergy; 2010 Apr; 40(4):582-9. PubMed ID: 20067482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients.
    Lõhmussaar E; Gschwendtner A; Mueller JC; Org T; Wichmann E; Hamann G; Meitinger T; Dichgans M
    Stroke; 2005 Apr; 36(4):731-6. PubMed ID: 15731479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population.
    Helgadottir A; Gretarsdottir S; St Clair D; Manolescu A; Cheung J; Thorleifsson G; Pasdar A; Grant SF; Whalley LJ; Hakonarson H; Thorsteinsdottir U; Kong A; Gulcher J; Stefansson K; MacLeod MJ
    Am J Hum Genet; 2005 Mar; 76(3):505-9. PubMed ID: 15640973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction.
    Maznyczka A; Mangino M; Whittaker A; Braund P; Palmer T; Tobin M; Goodall AH; Bradding P; Samani NJ
    Clin Sci (Lond); 2007 Jun; 112(7):411-6. PubMed ID: 17176247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.
    Crosslin DR; Shah SH; Nelson SC; Haynes CS; Connelly JJ; Gadson S; Goldschmidt-Clermont PJ; Vance JM; Rose J; Granger CB; Seo D; Gregory SG; Kraus WE; Hauser ER
    Hum Genet; 2009 Mar; 125(2):217-29. PubMed ID: 19130089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population.
    Tsai AK; Li N; Hanson NQ; Tsai MY; Tang W
    Atherosclerosis; 2009 Dec; 207(2):487-91. PubMed ID: 19596330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.
    Helgadottir A; Manolescu A; Thorleifsson G; Gretarsdottir S; Jonsdottir H; Thorsteinsdottir U; Samani NJ; Gudmundsson G; Grant SF; Thorgeirsson G; Sveinbjornsdottir S; Valdimarsson EM; Matthiasson SE; Johannsson H; Gudmundsdottir O; Gurney ME; Sainz J; Thorhallsdottir M; Andresdottir M; Frigge ML; Topol EJ; Kong A; Gudnason V; Hakonarson H; Gulcher JR; Stefansson K
    Nat Genet; 2004 Mar; 36(3):233-9. PubMed ID: 14770184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.
    Tcheurekdjian H; Via M; De Giacomo A; Corvol H; Eng C; Thyne S; Chapela R; Rodriguez-Cintron W; Rodriguez-Santana JR; Avila PC; Burchard EG;
    J Allergy Clin Immunol; 2010 Oct; 126(4):853-8. PubMed ID: 20810156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population.
    Koch W; Hoppmann P; Mueller JC; Schömig A; Kastrati A
    Genet Med; 2007 Feb; 9(2):123-9. PubMed ID: 17304054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations.
    Bevan S; Dichgans M; Wiechmann HE; Gschwendtner A; Meitinger T; Markus HS
    Stroke; 2008 Apr; 39(4):1109-14. PubMed ID: 18323512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia.
    van der Net JB; Versmissen J; Oosterveer DM; Defesche JC; Yazdanpanah M; Aouizerat BE; Steyerberg EW; Malloy MJ; Pullinger CR; Kane JP; Kastelein JJ; Sijbrands EJ
    Atherosclerosis; 2009 Apr; 203(2):472-8. PubMed ID: 18775537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
    Hakonarson H; Thorvaldsson S; Helgadottir A; Gudbjartsson D; Zink F; Andresdottir M; Manolescu A; Arnar DO; Andersen K; Sigurdsson A; Thorgeirsson G; Jonsson A; Agnarsson U; Bjornsdottir H; Gottskalksson G; Einarsson A; Gudmundsdottir H; Adalsteinsdottir AE; Gudmundsson K; Kristjansson K; Hardarson T; Kristinsson A; Topol EJ; Gulcher J; Kong A; Gurney M; Thorgeirsson G; Stefansson K
    JAMA; 2005 May; 293(18):2245-56. PubMed ID: 15886380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population.
    Kajimoto K; Shioji K; Ishida C; Iwanaga Y; Kokubo Y; Tomoike H; Miyazaki S; Nonogi H; Goto Y; Iwai N
    Circ J; 2005 Sep; 69(9):1029-34. PubMed ID: 16127181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden.
    Kostulas K; Gretarsdottir S; Kostulas V; Manolescu A; Helgadottir A; Thorleifsson G; Gudmundsson LJ; Thorsteinsdottir U; Gulcher JR; Stefansson K; Hillert J
    J Neurol Sci; 2007 Dec; 263(1-2):113-7. PubMed ID: 17655870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.